LyondellBasell’s introduces Purell EP370S
On June 4, LyondellBasell (LYB) announced Purell EP370S, which is a polypropylene heterophasic copolymer. According to the company, this material “allows for the energy efficient production of healthcare articles such as pharmaceutical packaging, labware, medical caps & closures and medical containers. Compared with other PP grades, Purell EP370S maintains its excellent toughness and physical properties at lower conversion temperatures. The high flowability enables also shorter cycle times.”
Rodney Fox, LYB’s marketing manager of European PP Healthcare and Caps and Closures division, noted, “Purell EP370S offers a good balance between physical and mechanical properties to meet the requirements of our customers in injection molding applications because of its good flowability and impact behavior.”
LyondellBasell’s stock performance
On June 8, LyondellBasell (LYB) rose 4.4% and closed at $118.09. LyondellBasell’s gain resulted in the stock trading 7.2% above its 100-day moving average price of $110.17, indicating an upward trend.
On a YTD (year-to-date) basis, LYB stock has gained 5.2%. Among its peers, PolyOne (POL), Eastman Chemical (EMN), and Celanese (CE) have gained 0.7%, 17.7%, and 9.7%, respectively, while Celanese (CE) has declined 9.7% YTD. LyondellBasell’s 14-day RSI (relative strength index) of 64 indicates that the stock is neither overbought nor oversold.
Investors could hold LyondellBasell indirectly by investing in the Vanguard Materials ETF (VAW), which gained 2.3% for the week. VAW invested 4.1% of its portfolio in LyondellBasell on June 8.